Immuneering Statistics
NASDAQ: IMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.86+0.03 (+0.78%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Immuneering by the numbers
Immuneering has a market capitalization of $249.7 million based on 64.70M shares outstanding. With trailing EPS of $-0.93, Immuneering is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.3% below its 50-day average and 22.9% below its 200-day average.
Average daily trading volume is 693.70K shares, or about $2.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMRX valuation vs. peer median
| Metric | IMRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $249.73M | $244.01M | +2% |
| Avg. volume | 693.70K | 442.65K | +57% |
Peer median across 8 companies: ZNTL, LFCR, VCRE, UPB, AKBA, AMRN, CAMP, PYXS.
Valuation
- Market cap
- $249.73M
- EPS (TTM)
- $-0.93
- Shares outstanding
- 64.70M
Price and trading
- Previous close
- 3.83
- Open
- 3.78
- Day range
- 3.74 – 3.92
- 52-week range
- 3.74 – 8.48
- 52-week change
- -36.82%
- Beta
- —
- Volume
- 747.56K
- Average volume
- 693.70K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 5, 2026
Additional statistics
- Market Cap
- 249.73M
- Forward Pe
- -3.07
- Eps
- -0.93
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.48
- Week52 Low
- 3.74
- Avg Volume
- 693.70K
- Shares Outstanding
- 64.70M
- Ma50
- 4.61
- Ma200
- 5.01
- Earnings Date
- Aug 5, 2026
- Pct From52w High
- -54.48%
- Pct From52w Low
- 3.21%